🇺🇸 FDA
Pipeline program

telmisartan

502.397

Approved small_molecule completed

Quick answer

telmisartan for Hypertension is a Approved program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim
Indication
Hypertension
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials